Primer: ILab (ILAB(DRUGDISCOVERY) KS) - May 2026
ILab is a privately held, venture-backed South Korean biotechnology company focused on developing novel small molecule drugs to modulate the...
87 Views
No more insights
𝛼SK or SearchENTITY
ILab (ILAB(DRUGDISCOVERY) KS EQUITY)
ILab (ILAB(DRUGDISCOVERY) KS EQUITY)
1
Analysis
Health Care • South Korea
The company develops small molecule immune response modulating drugs to address unmet medical needs. It focuses on the development of oral, small-molecule tumor necrosis factor (TNF) therapies designed to offer low immunogenicity for the treatment of rheumatoid arthritis and related diseases.
morex